CagriSema is a two-peptide amylin + GLP-1 combination
Supporting athletes in recovery from overtraining or injuries Stimulates collagen and group-specific aging (GAG) synthesis in the skin for increased firmness, thickness, and hydration Supports gut healing and overall gut health tissue regeneration
He is member of a data monitoring and safety board for Inventiva
TPN Supplementation: 0.41 mg/day typically added to IV nutrition solutions
Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing
The subcutaneous tissue surrounding the knee provides adequate proximity for peptide diffusion to ligaments, tendons, and the joint capsule
